Inhibition of hsp27 and hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells
Heat shock proteins (Hsps) modulate several cellular functions and are ubiquitously present in cell. Here, we investigated alterations in the expression of Hsps and explored functional consequences of the same. Moreover, effect of quercetin (Qctn), an inhibitor of Hsps, on chemotherapeutic drugs tre...
Gespeichert in:
Veröffentlicht in: | Cancer biology & therapy 2009-11, Vol.8 (22), p.2106-2113 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Heat shock proteins (Hsps) modulate several cellular functions and are
ubiquitously present in cell. Here, we investigated alterations in the
expression of Hsps and explored functional consequences of the same.
Moreover, effect of quercetin (Qctn), an inhibitor of Hsps, on
chemotherapeutic drugs treatment in hepatoma cells Hep3B and HepG2 was
investigated. We for the first time report that 5-fluorouracil (5-FU) and
carboplatin specifically induce expression of Hsp40 in addition to Hsp27 in
Hep3B and HepG2 cells. Induction of Hsps following exposure to sub lethal
dose of drugs is a cellular challenge to survival. However, under lethal
environmental conditions with reduced cell viability, cells fail to sustain the
induction of survival proteins, Hsp27 and Hsp40. Though Qctn itself, to
certain extent is cytotoxic to cells, it potentiates the pro-apoptotic action of 5-
FU and carboplatin, by inhibiting expression of Hsps. The increased cell killing
correlates with decreased levels of procaspase-3. Furthermore, siRNA
mediated knockdown of Hsp27 and Hsp40 diminishes survival of drugs
exposed cells. Altogether, our data provides clear evidence that Hsp27 and
40 promote cell survival and inhibition of their expression does not allow cells
to adapt to drug exposure and survive. Collectively, our novel findings on
compelling action of 5-FU or carboplatin following knockdown of Hsp40 and
that of Hsp27 highlights their strategic implications towards an effective
therapy against HCC. |
---|---|
ISSN: | 1538-4047 1555-8576 |
DOI: | 10.4161/cbt.8.22.9687 |